TrustMF Multi Cap Fund
The scheme seeks to generate long-term capital appreciation by predominantly investing in a diversified portfolio of equity & equity related instruments across large cap, mid cap and small cap stocks.
Growthvine rating: 2/5 — ranked #27 of 34 in category.
Fund basics
| Category | Equity: Multi Cap |
|---|
| NAV | ₹12.11 (as of 2026-11-13) |
|---|
| AUM | ₹973 Cr |
|---|
| Expense ratio | 1.93% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Aakash Manghani |
|---|
| Exit load | 1% for redemption within 180 days |
|---|
Performance & risk
| Standard deviation | 0.00% |
|---|
| Max drawdown | −13.27% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Over 5 years, captured 149.5% of NIFTY500 Multicap 50:25:25's upside and 89.9% of its downside.
Market cap allocation
| Large cap | 37.8% |
|---|
| Mid cap | 29.0% |
|---|
| Small cap | 33.2% |
|---|
Concentration
| Top 5 holdings | 16.4% |
|---|
| Top 10 holdings | 27.2% |
|---|
| Total holdings | 70 |
|---|
| Index overlap | 29.9% |
|---|
| Active share | 70.1% |
|---|
Top holdings
- ICICI Bank Ltd. — 5.4%
- TREPS 02-Nov-2026 — 4.2%
- Kotak Mahindra Bank Ltd. — 3.7%
- Laurus Labs Limited — 2.6%
- Lenskart Solutions Limited — 2.4%
- Eternal Limited — 2.3%
- Multi Commodity Exchange of India Ltd — 2.3%
- Aurobindo Pharma Ltd. — 2.1%
- HDFC Bank Ltd. — 2.1%
- Indian Hotels Co. Ltd — 2.1%
Top sectors
- Banking & Financial — 22.0%
- Pharma & Biotech — 11.9%
- Retail — 7.7%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 15.7% | Q1 (Top) | #3 of 33 |